Form 4: HealthEquity Executive Sells Shares

HealthEquity Inc. EVP, General Counsel Delano Ladd reported a sale of 7,726 shares of common stock on March 31, 2026.

Summary

• Delano Ladd, Executive Vice President and General Counsel of HealthEquity, Inc., reported a transaction on March 31, 2026.
• The transaction involved the sale of 7,726 shares of common stock.
• The sale was executed at a price of $82.5264 per share.
• Following this transaction, Mr. Ladd beneficially owns 101,122 shares of common stock directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as neutral to slightly negative due to the sale of shares by a key executive, although it is a routine disclosure and does not provide information on the company's performance.

Negatives

• An executive officer sold a significant number of shares (7,726).

Future Outlook

No forward-looking statements or guidance were provided in this filing.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from HealthEquity, Inc., are standard disclosures for insider transactions. While a single sale by an executive does not necessarily indicate a negative outlook for the company, it is a data point that investors often monitor to gauge insider confidence.

Stakeholder Impact

• Shareholders may view the sale of shares by an executive with some concern, potentially impacting short-term investor sentiment.

Key Dates

Recommendation

This filing is a routine Form 4 disclosure of an insider transaction and does not contain operational or financial performance data. Therefore, it does not provide sufficient information to warrant a buy or sell recommendation. A 'hold' recommendation is appropriate pending further company performance updates.

Keywords

HealthEquity, HQY, Form 4, insider trading, stock sale, executive compensation, beneficial ownership